Über das Unternehmen
- Firmenname (rechtlich): Hunan OUYA Pharmaceutical Co., Ltd
- Internationaler Name: 湖南欧亚药业有限公司 (Hunan Ouya Pharmaceutical Co., Ltd.), Hunan, China
- Marke / Handelsname: Ouya Pharmaceutical
- Registrierungsland: China
- Adresse: Hunan
Beschreibung:
Hunan Ouya Pharmaceutical, established in 2007, manufactures and trades chiral intermediates, digestive system, and cardiovascular system drug APIs, with GMP-compliant production for some of its API products and patented processes covering Biapenem intermediates, a mercaptotriazolium chloride intermediate, Cefoselis Hydrogen Sulfate, and industrial-scale prulifloxacin manufacturing. The company emphasizes mass production capability, rigorous quality control, and responsive customer service, distributing to markets across North America, Central/South America, Western and Eastern Europe, Australasia, Asia, the Middle East, and Africa.
Geschäftsaktivitäten
Pharmazeutische Wirkstoffe (API)
ExporteurAPI-Hersteller
Pharmazeutische Chemikalien
Hersteller
ATC-Klassifikation (Anatomisch-Therapeutisch-Chemisch)
Hersteller
Absatzmärkte
- Western Europe: Austria, Belgium, France
- Northern America: Bermuda, Canada, Greenland, Saint Pierre and Miquelon, United States
- Central America: Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama
- South America: Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Falkland Islands, French Guiana, Guyana, Paraguay, Peru, Suriname, Uruguay, Venezuela
Hauptprodukte/-dienstleistungen
- Pharmazeutische Wirkstoffe (API): Active Pharmaceutical Ingredients
- Vertrags- & Outsourcing-Dienstleistungen: Custom API Manufacturing
- Pharmazeutische Chemikalien: Olaparib, Adenine, Pharmaceutical Intermediates, 2-Chloromethyl 3-methyl-4[2,2,2 trifluoroethoxy] pyridine hydrochloride, (1S,3S,5S)-3-(Aminocarbonyl)-2-azabicyclo[3.1.0]hexane-2-carboxylic acid tert-butyl ester, (3S)-3-[4-[(2-Chloro-5-iodophenyl)methyl]phenoxy]tetrahydro-furan, 2-Amino-5-bromo-6-methylpyridine, (alphaS,betaR)-beta-(2,5-Difluorophenyl)-beta-hydroxy-alpha-methyl-1H-1,2,4-triazole-1-butanenitrile, Ethyldiisopropylamine, 2-(DI-N-PROPYLAMINO)ETHYLAMINE, N4-Benzoylcytosine, Fluorocytosine, 1-[2-[(2,4-Dimethylphenyl)thio]phenyl]piperazine hydrobromide, 1-(2,5-difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanone, 1-Boc-Piperazine, 1-(N-Boc-piperidine-4-ly)-boronic acid pinacol ester, 1,1-Dimethoxy-N,N-dimethyl-1-butanamine, 1,2,3-triacetyl-5-deoxy-β-D-Riboturanose, (1R,3S,4S)-3-[6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzimidazol-2-yl]-2-azabicyclo[2.2, 2-[(1S,2S)-1-Ethyl-2-bezyloxypropyl]-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]-3H-, 2-[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methylthio-1H-benzimidazole, 2-(6-chloro-2-methylpyrimidin-4-ylamino)-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide, 2-[(6-Chloro-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl)methyl]-4-fluorobenzonitrile, 2-Amino-1,2,3,4-tetrahydro-5,8-dimethoxy-2-naphthalenecarboxylic acid, 2-Amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol, 2-AMino-4-[(4-fluorobenzyl)aMino]-1-nitrobenzene(RETIGABINE inteMediate), 2-Amino-N-(2-chloro-6-methylphenyl)-5-thiazolecarboxamide, 2-Aminothiazole-4-carboxylic acid, 2-Azabicyclo[2.2.1]heptane-2-carboxylic acid, 3-(6-broMo-1H-benziMidazol-2-yl)-, 1,1-diMethylethyl e, 2’-deoxy-2’-fluoro-2’-C-methyluridine, 2-fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)Methyl)benzoic acid, 2-HYDROXY-4,5-DIMETHOXY BENZOIC ACID, 2-hydroxy-benzamid, 2-Hydroxypyridine-N-xoide, 2',3'-Di-O-acetyl-5'-Deoxy-5-fluorocytidine, (2R,3R)-3-(2,5-Difluorophenyl)-3-hydroxy-2-Methyl-4-(1H-1,2,4-triazol-1-yl)thio butyraMide, (2R,4S)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid, 2S CIS PNB(SIDE CHAIN for Meropenem), 3-[(1R)-(2,6- dichloro -3-fluorophenyl) ethoxy]-2- amino -5- bromopyridin, 3-(2-Chloroethyl)-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one, 3-[(3-AMINO-4-METHYLAMINO-BENZOYL)-PYRIDIN-2-YL-AMINO]-PROPIONIC ACID ETHYL ESTER, 3-Morpholin-4-yl-1-[4-(2-oxopiperidin-1-yl)phenyl]-5,6-dihydro-1H-pyridin-2-one, 3H-1,2,4-Triazole-3-thione,5-amino-4-(4-cyclopropyl-1-naphthalenyl)-2,4-dihydro-3H-1,2,4-Triazole-3-, 4-(1-Pyrrolidinylsulforylmenthyl)phenylhydrazine hydrochloride, 4-(2-BROMO-PHENYL)-PIPERAZINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER, 4-(3-chloropropyl)morpholine, 4-[3,5-bis(2-hydroxyphenyl)-1,2,4-triazol-1-yl]benzoic acid, 4-(4-cyclopropylnaphthalen-1-yl)-1H-1,2,4-triazole-5(4H)-thione, 4-[(4-Methyl-1-piperazinyl)methyl]benzoic acid dihydrochloride hemihydrate, 4-(6-aminopyridin-3-yl)piperazine-1-carboxylic, 4-Chloro-6,7-bis(2- methoxyethoxy) quinazoline, 4-CHLORO BUTYALDEHYDE DIMETHYL ACETAL, 4-Chlorobutanal diethyl acetal, 4-Chlorobutanal dimethyl acetal, 4-Chlorobutyraldehyde diethyl acetal, 4-cyanophenacyl bromide, 4-cyclopropylnaphthalen-1-aMine hydrochloride, 4-Dimethylamino butyaldehyde diethyl acetal, 4-Dimethylamino butyaldehyde dimethylacetal, 4-Hydrazinobenzoic acid, 4,4-Diethoxy-N,N-dimethyl-1-butanamine, 5-(2-fluorophenyl)- 1H-Pyrrole-3-carboxaldehyde, 5-Formyl-2,4-dimethyl-1H-pyrrole-3-carboxylic acid, (5R-cis)-Toluene-4-sulfonic acid 5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-yl)methyltetrahydrofur, 6-Ethylchenodeoxycholic acid, 6-fluoro-1-methyl-4-oxo-7-(1-piperazinyl)-4h-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid, 6-Fluoro-3-(4-piperidinyl)-1,2-benzisoxazole hydrochloride, 6-HYDROXY-7-METHOXY-3,4-DIHYDROQUINAZOLIN-4-ONE, 6,7-BIS(2-METHOXYETHOXY)QUINAZOLIN-4(1H)-ONE, 7-ketolithocholic Methyl ester, ACETIC ACID, 2-CHLORO-2-[2-(4-METHOXYPHENYL)HYDRAZINYLIDENE], ETHYL ESTER, AcotiaMide, AHU-377, (alphaS)-alpha-[[(1,1-Dimethylethoxy)carbonyl]amino]-3-hydroxytricyclo[3.3.1.13,7]decane-1-acetic ac, Boc-L-Tyrosine ethyl ester, Doripenem side chain/ASPC, (E)-3α-Hydroxy-6-Ethylidene-7-Keto-5β-Cholan-24-Oic Acid, (E)-6-Iodo-3-[2-(pyridin-2-yl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole, Eldecalcitol Intermediate（200636-42-6）, Eldecalcitol Intermediate(70550-73-1), Ethyl 2-(triphenylphosphoranylidene)propionate, Ethyl 6-fluoro-1-methyl-4-oxo-7-(1-piprazinyl)-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylate, Ethyl 6,7-difluoro-1-methyl-4-oxo-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylate, Ethyl 6,7-difluoro-2-ethylmercapto-4-hydroxyquinoline-3-carboxylate, Fingolimod hydrochloride, GS-7977, HEXYL CHLOROFORMATE, Ibrutinib intermediate-4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidine, Ibrutinib intermediate-(R)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amin, Imipenem & Panipenem intermediate,BCK, Isavuconazole API, ledipasvir interMediate, Lesinurad API, MAP(MVP), N-(4-CYANO-PHENYL)-GLYCINE, N-(5-amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine, N-Methyl-4-chloropyridine-2-carboxamide, N-OCTYLBENZENE, N-[(S)-(2,3,4,5,6-Pentafluorophenoxy)phenoxyphosphinyl]-L-alanine 1-methylethyl ester, Nintedanib intermediate-Methyl oxindole-6-carboxylate, Nintedanib intermediate-N-(4-aminophenyl)-N-methyl-2-(4-methylpiperazin-1-yl)acetamide, O-Desmorpholinopropyl Gefitinib, Palbociclib intermediate-6-Bromo-2-chloro-8-cyclopentyl-5-methylpyrido-[2,3-d]pyrimidin-7(8H)-one, Paliperidone, Panipenem side-chain, Piperazine, 1-(cyclopropylcarbonyl)-, Monohydrochloride, RETIGABINE DIHYDROCHLORIDE, Side chain of biapenem, Side chain of ertapenem, Side chain of Imipenem, TAK 438-1H-Pyrrole-3-carboxylic acid, 5-(2-fluorophenyl)-, ethyl ester, Tenofovir disoproxil
- ATC-Klassifikation (Anatomisch-Therapeutisch-Chemisch): Rosuvastatin Calcium, Atorvastatin calcium, Telmisartan, Adefovir/PMEA, Entecavir（GMP）, Pitavastatin Calc
Unsere Produkte & Dienstleistungen
Sell · Pharma Chemicals
![(1R,3S,4S)-3-[6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzimidazol-2-yl]-2-azabicyclo[2.2](/_next/image?url=https%3A%2F%2Fapi.pharmacountry.com%2Fuploads%2Fitems%2F1r3s4s-3-6-4455-tetramethyl-132-dioxabor-226112.jpg&w=640&q=75)
![2-[(1S,2S)-1-ethyl-2-bezyloxypropyl]-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]- 3H](/_next/image?url=https%3A%2F%2Fapi.pharmacountry.com%2Fuploads%2Fitems%2F2-1s2s-1-ethyl-2-bezyloxypropyl-24-dihyd-226060.jpg&w=640&q=75)
![3-[(1R)-(2,6- dichloro -3-fluorophenyl) ethoxy]-2- amino -5- bromopyridin](/_next/image?url=https%3A%2F%2Fapi.pharmacountry.com%2Fuploads%2Fitems%2F3-1r-26--dichloro--3-fluorophenyl-ethoxy-226083.jpg&w=640&q=75)
Sell · Pharma Chemicals
![3-Morpholin-4-yl-1-[4-(2-oxopiperidin-1-yl)phenyl]-5,6-dihydro-1H-pyridin-2-one](/_next/image?url=https%3A%2F%2Fapi.pharmacountry.com%2Fuploads%2Fitems%2F3-morpholin-4-yl-1-4-2-oxopiperidin-1-yl-226055.jpg&w=640&q=75)
Sell · Pharma Chemicals
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · Pharma Chemicals
Sell · Pharma Chemicals
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · Pharma Chemicals
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · Pharma Chemicals
![Ibrutinib intermediate-(R)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amin](/_next/image?url=https%3A%2F%2Fapi.pharmacountry.com%2Fuploads%2Fitems%2Fibrutinib-intermediate-r-3-4-phenoxyphen-226078.jpg&w=640&q=75)
Sell · Pharma Chemicals
![N-[(S)-(2,3,4,5,6-pentafluorophenoxy)phenoxyphosphinyl]-L-alanine 1-Methylethyl ester](/_next/image?url=https%3A%2F%2Fapi.pharmacountry.com%2Fuploads%2Fitems%2Fn-s-23456-pentafluorophenoxyphenoxyphosp-226115.jpg&w=640&q=75)
Sell · Pharma Chemicals
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Certifications
Bewertungen
(0)
(0)
(0)
(0)
(0)
Kommentare
Filter:
Sortieren nach:
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen